Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

3.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.4K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

829
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
829
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

968
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
968
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.1K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

492
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
492
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

855
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
855

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global trend and predictors of non-labelled sacubitril-valsartan dosing: results from IKNOW-HF survey.

ESC heart failure·2026
Same author

Changes in Pulmonary Artery Pressure Following Initiation of Guideline-Directed Medical Therapies in Patients With Heart Failure: Insights From GUIDE-HF.

Circulation. Heart failure·2026
Same author

iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025.

Heart views : the official journal of the Gulf Heart Association·2026
Same author

Association of the Timing of Acute Declines in Kidney Function in Acute Heart Failure With Cardiovascular and Kidney Outcomes.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Automatic activation of neurostimulation for central sleep apnea results in high nightly usage.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same author

Current Pharmacologic and Nonpharmacologic Decongestion Strategies in Acute Heart Failure: Evidence and Practical Guidance.

Journal of cardiac failure·2025
Same journal

Mineralocorticoid Receptor Antagonist Use in Contemporary Heart Failure Care.

Cardiac failure review·2026
Same journal

Obesity Definitions and Hospital Stay in Older Adults with Heart Failure: A Post Hoc Analysis of a Prospective Cohort.

Cardiac failure review·2026
Same journal

A Contemporary Perspective on Acute Decompensated Heart Failure Classification: A State-of-the-art Review from an International Expert Group.

Cardiac failure review·2026
Same journal

Valvular Heart Disease in Heart Failure with Preserved Ejection Fraction.

Cardiac failure review·2026
Same journal

Multimodality Imaging in Hypertrophic Cardiomyopathy.

Cardiac failure review·2026
Same journal

Lipoprotein(a): A Novel Risk Factor for Heart Failure and Biomarker of Prognosis? From Pathophysiology to Clinical Practice.

Cardiac failure review·2026
See all related articles

Related Experiment Video

Updated: Jan 28, 2026

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

3.4K

Ultrafiltration in Acute Heart Failure.

Maria Rosa Costanzo1

  • 1Advocate Heart Institute Naperville, Illinois, US.

Cardiac Failure Review
|March 9, 2019
PubMed
Summary
This summary is machine-generated.

Fluid overload causes over 1 million heart failure hospitalizations annually. Adjusting ultrafiltration rates based on patient vitals and kidney function improves decongestion and reduces heart failure events.

Keywords:
Diureticsfluid overloadheart failureultrafiltrationvenous congestion

More Related Videos

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.8K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.9K

Related Experiment Videos

Last Updated: Jan 28, 2026

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

3.4K
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.8K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.9K

Area of Science:

  • Cardiology
  • Nephrology
  • Critical Care Medicine

Background:

  • Congestion is a primary driver of heart failure hospitalizations, with recurrent fluid overload leading to poor patient outcomes.
  • Current pharmacological treatments for acute heart failure have not effectively reduced adverse outcomes associated with congestion.
  • Simplified ultrafiltration devices offer potential for fluid removal in less acute settings, but their safety and efficacy remain variable.

Purpose of the Study:

  • To evaluate the efficacy and safety of ultrafiltration in managing heart failure congestion.
  • To investigate the impact of adjusting ultrafiltration rates based on patient vital signs and renal function.
  • To identify key areas for future research in ultrafiltration therapy for heart failure.

Main Methods:

  • Review of existing literature on ultrafiltration devices and their application in heart failure management.
  • Analysis of studies comparing variable ultrafiltration rates adjusted to patient parameters versus fixed-rate protocols.
  • Examination of factors influencing ultrafiltration success, including patient selection and venous access.

Main Results:

  • Unresolved congestion is a stronger predictor of adverse heart failure outcomes than increases in serum creatinine.
  • Ultrafiltration, particularly when rates are adjusted to vital signs and renal function, shows promise for effective decongestion.
  • Adjusted ultrafiltration strategies are associated with improved decongestion and a reduction in heart failure events.

Conclusions:

  • Optimizing ultrafiltration rates based on individual patient physiological status is crucial for effective decongestion in heart failure.
  • Further investigation is needed to refine patient selection criteria, optimize fluid removal rates, and address complications and costs associated with ultrafiltration.
  • Ultrafiltration represents a potential therapeutic avenue for managing heart failure congestion, warranting continued research and development.